Ask the Experts: Vaccine confidence in the ‘post-truth’ world
In line with World Immunization Week, we’ve brought together a panel of experts to discuss the issues surrounding vaccine confidence in a ‘post-truth’ world.
Browsing: Vaccines
RTS,S vaccine to enter Phase IV trials in Malawi, Kenya and Ghana
A large-scale trial of RTS,S – the world’s first malaria vaccine to provide partial protection – is due to commence in Malawi, Kenya and Ghana.
ECCMID19: Vaccine-preventable diseases on the rise in Venezuela
Vaccine-preventable diseases – including measles and diphtheria – have surged in crisis-hit Venezuela, according to research presented at ECCMID.
Institutional trust and misinformation: the impact on Ebola control efforts
A new population-based survey has reported that low levels of public trust could have impacted the Ebola control efforts in the Democratic Republic of Congo, with a quarter of individuals not believing the virus was real and refusing vaccination.
Developing a maternal vaccine against respiratory syncytial virus
Recently, many programs developing respiratory syncytial virus vaccines have sought to vaccinate pregnant women in an effort to enhance maternal immunity. Find out about the challenges and the latest developments.
Ethically possible and ethically required: The path towards equitable inclusion of pregnant women in vaccine development
Vaccination during pregnancy provides important benefits, so why are pregnant women excluded from clinical trials? Learn more about the path towards including this group in vaccine development for both routine and emergency vaccinations.
Mayaro virus: novel synthetic DNA vaccine provides immunity in preclinical trials
Researchers from the Wistar Institute have engineered a synthetic DNA vaccine able to provide potent immunity against the emerging Mayaro virus in mice models.
Micromotor formulation shows promise for oral vaccination
A biomimetic, micromotor vaccine formulation has shown promising results in immunizing against Staphylococcus aureus in mouse models.
Takeda’s dengue vaccine meets primary endpoint in Phase III: January’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for a vaccine protecting against six diseases, positive clinical trial results for bacteraemia and dengue vaccines and new funding for CRSIPR-based antimicrobials.
Infographic: The pipeline for RSV vaccines
In this infographic we take a look at the RSV vaccines currently in the clinical pipeline and their target population from Phase I to Phase III.
